Developing a first-in-class therapeutic for chronic visceral pain using venom derived peptides (NHMRC Development Grant administered by SAHMRI) (2022–2024)

Grant type:
South Australian Health and Medical Research Institute Limited
Researchers:
Funded by:
South Australian Health and Medical Research Institute Limited